Form4insider filings, from the source

Insider · CIK 0001691428

UBS Oncology Impact Fund L.P.

Files at: TCRR, HARP, SBPH, SNSS. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $13.5M · 2sales $6,258 · 1net $13.5M
$10k$10k$1M$1M$100M$100MbuyssalesFeb 11Feb 12Feb 14Feb 15Feb 17Feb 18Feb 20

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Feb 19, 2019 PForm 4 →Feb 21, 6:06 pm ESTTCR2 THERAPEUTICS INC.TCRR666,667$15.00$10,000,0053,370,982+24.7% plan?
Feb 19, 2019 CForm 4 →Feb 21, 6:06 pm ESTTCR2 THERAPEUTICS INC.TCRR2,704,315——2,704,315— plan?
Feb 12, 2019 PForm 4 →Feb 14, 5:34 pm ESTHarpoon Therapeutics, Inc.HARP250,000$14.00$3,500,0003,898,422+6.85% plan?
Feb 12, 2019 SForm 4 →Feb 14, 5:34 pm ESTHarpoon Therapeutics, Inc.HARP447$14.00$6,2583,648,422−0.01% plan?
Feb 12, 2019 CXForm 4 →Feb 14, 5:34 pm ESTHarpoon Therapeutics, Inc.HARP3,648,869$0.0492$6,2533,648,869— plan?

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Feb 19, 2019 CForm 4 →Feb 21, 6:06 pm ESTTCR2 THERAPEUTICS INC.TCRR16,750,000——0—
Feb 12, 2019 CXForm 4 →Feb 14, 5:34 pm ESTHarpoon Therapeutics, Inc.HARP3,648,869——0—